ストックスクリーナーアプリを入手
2.09
0.48%
-0.01
前日終値:
$2.10
開ける：
$2.09
24時間の取引高:
73,063
Relative Volume:
0.44
時価総額：
$36.25M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
-24.28%
1年 パフォーマンス:
-37.98%
1日の値動き範囲:
$2.08
$2.0956
1週間の範囲:
$2.08
$2.10
52週間の値動き範囲:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
MURA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.09 | 36.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-04 | 開始されました | Morgan Stanley | Overweight |
Mural Oncology Plc (MURA) 最新ニュース
Citadel Group discloses 1.32% stake in Mural Oncology - Investing.com
What drives Mural Oncology plc stock priceLow Risk Investment Ideas & Rapid Capital Gain - earlytimes.in
Is Mural Oncology plc stock attractive for ETFsJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Why Mural Oncology plc stock remains a top recommendation - newser.com
Will Mural Oncology plc stock benefit from green energy trendsTrade Entry Report & Safe Capital Growth Plans - newser.com
Citadel Group discloses 1.32% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Is Mural Oncology plc stock ready for a breakoutJuly 2025 Chart Watch & Momentum Based Trading Ideas - newser.com
Citadel discloses 1.31% stake in Mural Oncology By Investing.com - Investing.com India
Citadel discloses 1.31% stake in Mural Oncology - Investing.com
What candlestick patterns are forming on Mural Oncology plcJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Is Mural Oncology plc a candidate for recovery playJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
Citadel Group discloses 1.3% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.3% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - MarketScreener
Why Mural Oncology plc stock is favored by pension fundsWeekly Trade Recap & Daily Profit Maximizing Trade Tips - newser.com
Citadel Group discloses 1.26% stake in Mural Oncology By Investing.com - Investing.com Canada
Is it too late to sell Mural Oncology plcPortfolio Profit Report & Community Supported Trade Ideas - newser.com
How Mural Oncology plc stock performs during Fed tightening cyclesPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - newser.com
Combining price and volume data for Mural Oncology plc - newser.com
Is Mural Oncology plc stock attractive for growth ETFsEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Citadel Group discloses 1.23% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.23% stake in Mural Oncology - Investing.com
Mural Oncology plc Stock Analysis and ForecastPrice Action Trading & Discover Top Gainers in Every Sector - earlytimes.in
What analysts say about Mural Oncology plc stockSector Rotation Strategies & Get The Analyst Consensus With One Click - earlytimes.in
Mural Oncology CFO Cutler sells $14939 in shares By Investing.com - Investing.com South Africa
Mural oncology CMO Goodman sells $10k in shares By Investing.com - Investing.com Nigeria
Mural oncology CMO Goodman sells $10k in shares - Investing.com
Mural Oncology CFO Cutler sells $14939 in shares - Investing.com
Citadel Group discloses 1.28% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Mural Oncology Plc (MURA) 財務データ
Mural Oncology Plc (MURA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Mural Oncology Plc (MURA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Goodman Vicki L | Chief Medical Officer |
Nov 10 '25 |
Sale |
2.08 |
5,036 |
10,475 |
84,727 |
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):